Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Additional Phase 3 studies are expected to report results later this year before the medication moves to the FDA review process
131 Recognizing these adaptive circuits enables the design of multiplexed therapeutic interventions to forestall resistance
First-in-elephant, proof-of-concept vaccination study Study design Study elephants Equivalent to phase I vaccine trial standards, healthy adult elephants rather than EEHV-susceptible calves were chosen for this first-in-elephant proof-of-concept study
Biopotency in this context means the pharmacodynamic effect of a given amount via the intestinal route vs the same dose i.v
US$ 23.03
US$ 22.62
US$ 25.89
US$ 25.07
US$ 27.86
US$ 28.30
US$ 24.13
US$ 21.32
US$ 29.52
